-
4
-
-
48749140867
-
-
Sakai K., Ishiguro Y., Funakoshi K., Ueno K., Suemune H. Tetrahedron Lett. 25:1984;961-964.
-
(1984)
Tetrahedron Lett.
, vol.25
, pp. 961-964
-
-
Sakai, K.1
Ishiguro, Y.2
Funakoshi, K.3
Ueno, K.4
Suemune, H.5
-
8
-
-
0033828416
-
-
Tanaka M., Imai M., Fujio M., Sakamoto E., Takahashi M., Eto-Kato Y., Wu X.M., Funakoshi K., Sakai K., Suemune H. J. Org. Chem. 65:2001;5806-5816.
-
(2001)
J. Org. Chem.
, vol.65
, pp. 5806-5816
-
-
Tanaka, M.1
Imai, M.2
Fujio, M.3
Sakamoto, E.4
Takahashi, M.5
Eto-Kato, Y.6
Wu, X.M.7
Funakoshi, K.8
Sakai, K.9
Suemune, H.10
-
10
-
-
0000070118
-
-
Barnhart R.W., Wang X., Noheda P., Bergens S.H., Whelan J., Bosnich B. J. Am. Chem. Soc. 116:1994;1821-1830.
-
(1994)
J. Am. Chem. Soc.
, vol.116
, pp. 1821-1830
-
-
Barnhart, R.W.1
Wang, X.2
Noheda, P.3
Bergens, S.H.4
Whelan, J.5
Bosnich, B.6
-
12
-
-
0025763126
-
-
. An exception where hydroacylation yields a 5-6 fused ring system in preference to the strained 5-5 system is found in the work of Gable and Benz: Gable K.P., Benz G.A. Tetrahedron Lett. 32:1991;3473-3476.
-
(1991)
Tetrahedron Lett.
, vol.32
, pp. 3473-3476
-
-
Gable, K.P.1
Benz, G.A.2
-
14
-
-
0032957154
-
-
For chelation-assisted intermolecular hydroacylation, see: (a) Jun, C. H.; Hong, J. B.; Lee, D. Y. Synlett 1999, 1-12; (b) Jun, C. H.; Lee, H.; Hong, J. B. J. Org. Chem. 1997, 62, 1200-1201.
-
(1999)
Synlett
, pp. 1-12
-
-
Jun, C.H.1
Hong, J.B.2
Lee, D.Y.3
-
15
-
-
0000685510
-
-
For chelation-assisted intermolecular hydroacylation, see: (a) Jun, C. H.; Hong, J. B.; Lee, D. Y. Synlett 1999, 1-12; (b) Jun, C. H.; Lee, H.; Hong, J. B. J. Org. Chem. 1997, 62, 1200-1201.
-
(1997)
J. Org. Chem.
, vol.62
, pp. 1200-1201
-
-
Jun, C.H.1
Lee, H.2
Hong, J.B.3
-
16
-
-
0005160076
-
-
US Patent 6 096 780, 2000
-
Derivatives of these compounds, most notably the tetrahydrobenzothiepines, exhibit diverse biological activity. For examples, see: (a) Shiraishi, M.; Baba, M.; Aramaki, Y.; Nishimura, O.; Kanzaki, N. US Patent 6 096 780, 2000; (b) Lee, L. F.; Banerjee, S. C.; Huang, H. C.; Li, J. J.; Miller, R. E.; Reitz, D. B.; Tremont, S. J. US Patent 5 994 391, 1999; (c) Frick, W.; Enhsen A.; Glombik, H.; Heuer, H. US Patent 6 221 897, 2001.
-
-
-
Shiraishi, M.1
Baba, M.2
Aramaki, Y.3
Nishimura, O.4
Kanzaki, N.5
-
17
-
-
0005167548
-
-
US Patent 5 994 391, 1999
-
Derivatives of these compounds, most notably the tetrahydrobenzothiepines, exhibit diverse biological activity. For examples, see: (a) Shiraishi, M.; Baba, M.; Aramaki, Y.; Nishimura, O.; Kanzaki, N. US Patent 6 096 780, 2000; (b) Lee, L. F.; Banerjee, S. C.; Huang, H. C.; Li, J. J.; Miller, R. E.; Reitz, D. B.; Tremont, S. J. US Patent 5 994 391, 1999; (c) Frick, W.; Enhsen A.; Glombik, H.; Heuer, H. US Patent 6 221 897, 2001.
-
-
-
Lee, L.F.1
Banerjee, S.C.2
Huang, H.C.3
Li, J.J.4
Miller, R.E.5
Reitz, D.B.6
Tremont, S.J.7
-
18
-
-
0005221866
-
-
US Patent 6 221 897, 2001
-
Derivatives of these compounds, most notably the tetrahydrobenzothiepines, exhibit diverse biological activity. For examples, see: (a) Shiraishi, M.; Baba, M.; Aramaki, Y.; Nishimura, O.; Kanzaki, N. US Patent 6 096 780, 2000; (b) Lee, L. F.; Banerjee, S. C.; Huang, H. C.; Li, J. J.; Miller, R. E.; Reitz, D. B.; Tremont, S. J. US Patent 5 994 391, 1999; (c) Frick, W.; Enhsen A.; Glombik, H.; Heuer, H. US Patent 6 221 897, 2001.
-
-
-
Frick, W.1
Enhsen, A.2
Glombik, H.3
Heuer, H.4
-
22
-
-
0005221867
-
-
note
-
3), δ 205.7, 142.0, 138.0, 130.6, 130.4, 129.7, 125.6, 43.0, 39.7, 34.2, 15.3; LRMS (EI) m/z (%): 192 (65), 145 (100), 136 (28), 131 (18), 121 (25), 108 (18); HRMS (EI) m/z: calcd: 192.0608. Found: 192.0599.
-
-
-
-
24
-
-
0005124014
-
-
note
-
Propargyl sulfides similarly failed to cyclize.
-
-
-
|